Evaluation of the clinical equivalence of biosimilars to their reference drugs in the treatment of rheumatoid arthritis: a Meta-analysis

CHEN Yao; ZHOU Qing-xin; ZENG Bao-qi; YANG Ji-chun; GAO Le; YAN Yu-song; SUN Feng

doi:10.3969/j.issn.1003-3734.2021.08.009

Home>Articles>Evaluation of the clinical equivalence of biosimilars to their reference drugs in the treatment of rheumatoid arthritis: a Meta-analysis

DOI: 10.3969/j.issn.1003-3734.2021.08.009

Evaluation of the clinical equivalence of biosimilars to their reference drugs in the treatment of rheumatoid arthritis: a Meta-analysis

CHEN Yao

ZHOU Qing-xin

ZENG Bao-qi

YANG Ji-chun

GAO Le

YAN Yu-song

SUN Feng

Machine-generated Keywords：

Publication Date：2021-04-30

Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)

Pages：9( 723-731 )

Chinese Journal of New Drugs

ISTICPKU

ISSN：1003-3734

Year, Vol.(Issue)：2021,30(8)